Ingredient or product comparison
GHK-Cu Concentration and Application Frequency: Clinical Research vs Commercial Claims
0.01–0.1% Modest collagen I upregulation in vitro; minimal clinical trial data for wrinkle depth reduction Twice daily Subtle improvement in skin texture and hydration; not sufficient for deep wrinkles Entry-level therapeutic threshold. Suitable for prevention
This source-based comparison does not add ratings or recommend a winner.
- 0.01–0.1%
- Modest collagen I upregulation in vitro; minimal clinical trial data for wrinkle depth reduction
- Twice daily
- Subtle improvement in skin texture and hydration; not sufficient for deep wrinkles
- Entry-level therapeutic threshold. Suitable for prevention, not correction
- 0.5–1.0%
- Multiple RCTs showing 15–23% increase in collagen density markers; statistically significant reduction in fine line depth
- Twice daily for 12+ weeks
- Measurable reduction in fine lines, improved skin elasticity, enhanced wound healing response
- Gold standard concentration range. Clinically validated, well-tolerated
- 1.5–2.0%
- Limited additional benefit vs 1.0%; increased irritation risk in sensitive skin
- Once daily or twice daily with tolerance monitoring
- Marginal additional collagen synthesis; higher risk of transient erythema
- Upper therapeutic limit. Use only if 1.0% shows inadequate response
- >2.0%
- No peer-reviewed evidence of superior efficacy; risk of free copper toxicity and oxidative stress
- Not recommended
- Potential for irritation, inflammation, and paradoxical collagen degradation
- Exceeds receptor saturation point. More is not better